Article
Predictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis.
PloS one - 1 Jan 2013
Qiu Mantang, Yang Xin, Hu Jingwen, Ding Xiangxiang, Jiang Feng, Yin Rong, Xu Lin
Abstract excerpt
BACKGROUND: The correlation between xeroderma pigmentosum group D (XPD) polymorphisms (Lys751Gln and Asp312Asn) and clinical outcomes of non-small cell lung cancer (NSCLC) patients, who received platinum-based chemotherapy (Pt-chemotherapy), is still inconclusive. This meta-analysis was aimed to systematically review published evidence and ascertain the exact role of XPD polymorphisms. METHODS: Databases of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
